HTRA1-targeted small molecules as therapies for Alzheimer's disease.
<p style="margin-left:0cm; margin-right:0cm">Alzheimer’s disease remains one of the most pressing neurodegenerative disorders, with limited treatment options, making the identification of novel therapeutic targets a crucial research challenge. In this study, we focused on the HtrA serine peptidase 1 (HTRA1) recep
Authors
- William Lin (ORCID: https://orcid.org/0009-0005-7819-4583)
Publication Details
- Journal
- European Science Review
- Published
- 2025-05-30
- DOI
- https://doi.org/10.29013/esr-25-3.4-7-21
- Primary Topic
- Cholinesterase and Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00